Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sasser AK"'
Autor:
Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2016, Iss Issue 1, Pp 13-27 (2016)
Tineke Casneuf,1 Amy E Axel,2 Peter King,2 John D Alvarez,2 Jillian L Werbeck,3 Tinne Verhulst,1 Karin Verstraeten,1 Brett M Hall,2 A Kate Sasser2 1Janssen Research and Development, Beerse, Belgium; 2Janssen Research and Development, Spring House, PA
Externí odkaz:
https://doaj.org/article/6f201d7c161d4e79a4b2094aa928728e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gianluca Storci, Pasquale Sansone, Thomas J. Rosol, Tim H M Huang, Michael W.Y. Chan, Simona Tavolari, A. Kate Sasser, Massimiliano Bonafè, Jillian L. Werbeck, Frank C. Marini, Adam W. Studebaker, Brett Hall
Publikováno v:
Cancer Research. 68:9087-9095
Common sites of breast cancer metastasis include the lung, liver, and bone, and of these secondary metastatic sites, estrogen receptor α (ERα)–positive breast cancer often favors bone. Within secondary organs, cancer cells would predictably encou
Autor:
Hiemstra IH; Genmab B.V., Utrecht, the Netherlands., Santegoets KCM; Genmab B.V., Utrecht, the Netherlands., Janmaat ML; Genmab B.V., Utrecht, the Netherlands., De Goeij BECG; Genmab B.V., Utrecht, the Netherlands., Ten Hagen W; Genmab B.V., Utrecht, the Netherlands., van Dooremalen S; Genmab B.V., Utrecht, the Netherlands., Boross P; Genmab B.V., Utrecht, the Netherlands., van den Brakel J; Genmab B.V., Utrecht, the Netherlands., Bosgra S; Genmab B.V., Utrecht, the Netherlands., Andringa G; Genmab B.V., Utrecht, the Netherlands., van Kessel-Welmers B; Genmab B.V., Utrecht, the Netherlands., Verzijl D; Genmab B.V., Utrecht, the Netherlands., Hibbert RG; Genmab B.V., Utrecht, the Netherlands., Frerichs KA; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Mutis T; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Ahmadi T; Genmab Inc, Princeton, NJ, USA., Satijn D; Genmab B.V., Utrecht, the Netherlands., Sasser AK; Genmab Inc, Princeton, NJ, USA., Breij ECW; Genmab B.V., Utrecht, the Netherlands. Electronic address: ebj@genmab.com.
Publikováno v:
EBioMedicine [EBioMedicine] 2023 Jul; Vol. 93, pp. 104663. Date of Electronic Publication: 2023 Jun 26.
Autor:
Kemper K; Genmab, Utrecht, The Netherlands., Gielen E; Genmab, Utrecht, The Netherlands., Boross P; Genmab, Utrecht, The Netherlands., Houtkamp M; Genmab, Utrecht, The Netherlands., Plantinga TS; Genmab, Utrecht, The Netherlands., de Poot SA; Genmab, Utrecht, The Netherlands., Burm SM; Genmab, Utrecht, The Netherlands., Janmaat ML; Genmab, Utrecht, The Netherlands., Koopman LA; Genmab, Utrecht, The Netherlands., van den Brink EN; Genmab, Utrecht, The Netherlands., Rademaker R; Genmab, Utrecht, The Netherlands., Verzijl D; Genmab, Utrecht, The Netherlands., Engelberts PJ; Genmab, Utrecht, The Netherlands., Satijn D; Genmab, Utrecht, The Netherlands., Sasser AK; Genmab, Princeton, NJ, USA., Breij EC; Genmab, Utrecht, The Netherlands ebj@genmab.com.
Publikováno v:
Life science alliance [Life Sci Alliance] 2022 Sep 08; Vol. 5 (11). Date of Electronic Publication: 2022 Sep 08 (Print Publication: 2022).
Autor:
Soong D; Janssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA. david.soong@caa.columbia.edu., Stratford J; Q2 Solutions, EA Genomics, Morrisville, NC, USA., Avet-Loiseau H; Unite de Genomique du Myelome, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Bahlis N; University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada., Davies F; Myeloma Institute, Little Rock, AR, USA., Dispenzieri A; Mayo Clinic, Division of Hematology, Rochester, MN, USA., Sasser AK; Genmab, Princeton, NJ, USA., Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA., Qi M; Janssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA., Brown C; OmicSoft Corporation, Cary, NC, USA., Jones W; Q2 Solutions, EA Genomics, Morrisville, NC, USA., Keats JJ; Translational Genomics Research Institute, Phoenix, AZ, USA., Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Chiu C; Janssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA., Powers J; Q2 Solutions, EA Genomics, Morrisville, NC, USA., Schaffer M; Janssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.
Publikováno v:
BMC bioinformatics [BMC Bioinformatics] 2020 Mar 06; Vol. 21 (1), pp. 98. Date of Electronic Publication: 2020 Mar 06.
Autor:
Adams HC 3rd; Janssen Research & Development, LLC, Spring House, Pennsylvania., Stevenaert F; Janssen Research & Development, Beerse, Belgium., Krejcik J; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.; Department of Hematology, Vejle Hospital and University of Southern Denmark, Vejle, Denmark., Van der Borght K; Janssen Research & Development, Beerse, Belgium., Smets T; Janssen Research & Development, Beerse, Belgium., Bald J; Janssen Research & Development, LLC, Spring House, Pennsylvania., Abraham Y; Janssen Research & Development, Beerse, Belgium., Ceulemans H; Janssen Research & Development, Beerse, Belgium., Chiu C; Janssen Research & Development, LLC, Spring House, Pennsylvania., Vanhoof G; Janssen Research & Development, Beerse, Belgium., Usmani SZ; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, North Carolina., Plesner T; Department of Hematology, Vejle Hospital and University of Southern Denmark, Vejle, Denmark., Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Nijhof I; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Lokhorst HM; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Mutis T; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., van de Donk NWCJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Sasser AK; Genmab US, Inc, Princeton, New Jersey., Casneuf T; Janssen Research & Development, Beerse, Belgium.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2019 Mar; Vol. 95 (3), pp. 279-289. Date of Electronic Publication: 2018 Dec 11.
Autor:
van de Donk NWCJ; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Casneuf T; Janssen Research& Development, Beerse, Belgium., Di Cara A; Quartz Bio, Geneva, Switzerland., Parren PW; Genmab, Utrecht, The Netherlands.; Department of Cancer and inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, the Netherlands., Zweegman S; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., van Kessel B; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Lokhorst HM; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Usmani SZ; Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC, USA., Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Richardson PG; Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chiu C; Janssen Research& Development, Spring House, PA, USA., Mutis T; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Nijhof IS; Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands., Sasser AK; Janssen Research& Development, Spring House, PA, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Feb; Vol. 184 (3), pp. 475-479. Date of Electronic Publication: 2018 Feb 07.
Autor:
Dimopoulos MA; The National and Kapodistrian University of Athens, Greece mdimop@med.uoa.gr., San-Miguel J; Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain., Belch A; Department of Oncology, University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada., White D; QEII Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada., Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France., Cook G; St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, UK., Leiba M; Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Morton J; Icon Cancer Care, South Brisbane, QLD, Australia., Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Takezako N; Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan., Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Sutherland HJ; Leukemia/Bone Marrow Transplant Program, University of British Columbia, Vancouver, Canada., Lalancette M; CHU de Québec Research Center, Faculty of Medicine, Laval University, Canada., Magen H; Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel., Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan., Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea., Prince HM; Cabrini Hospital, Epworth HealthCare and Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia., Cochrane T; Gold Coast University Hospital, Southport, QLD, Australia., Oriol A; Institut Català d'Oncologia i Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain., Bahlis NJ; University of Calgary, Arnie Charbonneau Cancer Institute, Alberta, Canada., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., O'Rourke L; Janssen Research & Development, LLC, Spring House, PA, USA., Wu K; Janssen Research & Development, LLC, Spring House, PA, USA., Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA., Casneuf T; Janssen Research & Development, Beerse, Belgium., Chiu C; Janssen Research & Development, LLC, Spring House, PA, USA., Soong D; Janssen Research & Development, LLC, Spring House, PA, USA., Sasser AK; Genmab US, Inc, Princeton, NJ, USA., Khokhar NZ; Janssen Research & Development, LLC, Spring House, PA, USA., Avet-Loiseau H; Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France., Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
Publikováno v:
Haematologica [Haematologica] 2018 Dec; Vol. 103 (12), pp. 2088-2096. Date of Electronic Publication: 2018 Sep 20.
Autor:
Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia aspencer@netspace.net.au., Lentzsch S; Division of Hematology/Oncology, Columbia University, New York, NY, USA., Weisel K; Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tübingen, Germany., Avet-Loiseau H; Unite de Genomique du Myelome, CHU Rangueil, Toulouse, France., Mark TM; Department of Medicine, University of Colorado, Aurora, CO, USA., Spicka I; Clinical Department of Haematology, 1 Medical Department, Charles University in Prague, Czech Republic., Masszi T; Department of Haematology and Stem Cell Transplantation, St László Hospital, 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary., Lauri B; Department of Hematology, Sunderbyn Hospital, Luleå, Sweden., Levin MD; Albert Schweitzer Hospital Department of Internal Medicine, Dordrecht, the Netherlands., Bosi A; Department of Hematology, Careggi Hospital and University of Florence, Italy., Hungria V; Irmandade Da Santa Casa De Misericordia De São Paulo, Brazil., Cavo M; 'Seràgnoli' Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanamdo, South Korea., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Quach H; St. Vincent's Hospital, University of Melbourne, Australia., Lee C; Royal Adelaide Hospital, North Terrace, Australia., Barreto W; Hospital Santa Marcelina, São Paulo, Brazil., Corradini P; Fondazione IRCCS Instituto Nazionale dei Tumori, University of Milan, Italy., Min CK; Seoul St. Mary's Hospital, South Korea., Scott EC; Oregon Health & Science University, Portland, OR, USA., Chanan-Khan AA; Mayo Clinic Florida, Jacksonville, FL, USA., Horvath N; Royal Adelaide Hospital, North Terrace, Australia., Capra M; Instituto do Cancer-Hospital Mae de Deus, Porto Alegre, Brazil., Beksac M; Ankara University, Turkey., Ovilla R; Hospital Angeles Lomas, Naucalpan de Juárez y alrededores, México., Jo JC; Ulsan University Hospital, South Korea., Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, South Korea., Sonneveld P; Erasmus Medical Center, Rotterdam, the Netherlands., Soong D; Janssen Research & Development, LLC, Spring House, PA, USA., Casneuf T; Janssen Research & Development, Beerse, Belgium., Chiu C; Janssen Research & Development, LLC, Spring House, PA, USA., Amin H; Janssen Research & Development, LLC, Raritan, NJ, USA., Qi M; Janssen Research & Development, LLC, Spring House, PA, USA., Thiyagarajah P; Janssen Research & Development, High Wycombe, UK., Sasser AK; Genmab US, Inc, Princeton, NJ, USA., Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA., Mateos MV; University Hospital of Salamanca/IBSAL, Spain.
Publikováno v:
Haematologica [Haematologica] 2018 Dec; Vol. 103 (12), pp. 2079-2087. Date of Electronic Publication: 2018 Sep 20.